Stigma is a well-documented barrier to effective individual and community response to mental illness and, in recent years, is a recognized impediment to prevention and treatment of substance use disorders (SUDs). This study uses focus group data to explore stigmatizing views of medication assisted recovery (MAR) among those in recovery and the people, organizations, and communities that surround them, with attention to implications for long-term recovery. Across groups, we find consistent themes that MAR simply trades one drug for another, MAR should be used only as a stepping-stone to full abstinence, and that long-term use of MAR indicates ineffectiveness or treatment failure. Data suggest the prevalence of these perceptions leads those in recovery and providers to see MAR as a last resort treatment, encourages individuals to discontinue MAR before they are ready, and as result increases risk of relapse and overdose.
AckerCaroline J.2002. Creating the American Junkie: Addiction Research in the Classic Era of Narcotic Control. Baltimore, MD: Johns Hopkins University Press.
2.
AmatoLauraMinozziSilviaDavoliMarinaVecchiSomona. 2011. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cohcrane Database of Systematic Reviews 10(CD004147). John Wiley & Sons, Ltd.
3.
Andraka-ChristouBarbara. 2020. The Opioid Fix: America’s Addiction Crisis and the Solution They Don’t Want You to Have. Baltimore, MD: Johns Hopkins University Press.
4.
Andraka-ChristouBarbaraRandall-KischOliviaTotaramRachel. 2021. “Designing an ‘Ideal’ Substance Use Disorder Treatment Center: Perspectives of People Who Have Utilized Medications for Opioid Use Disorder.”Qualitative Health Research31:512–22. doi:10.1177/1049732320971231.
5.
BazeleyPatJacksonKristi. 2013. Qualitative Data Analysis with NVivo. 2nd ed.Los Angeles, CA: Sage Publications.
6.
BellJamesStrangJohn. 2020. “Medication Treatment of Opioid Use Disorder.”Biological Psychiatry87(1):82–88. doi:10.1016/j.biopsych.2019.06.020.
7.
BentzleyBrandon S.BarthKelly S.BackSudie E.BookSarah W.2015. “Discontinuation of Buprenorphine Maintenance Therapy: Perspectives and Outcomes.”Journal of Substance Abuse Treatment52:48–57. doi:10.1016/j.jsat.2014.12.011.
8.
BirtLindaScottSuzanneCaversDebbieCampbellChristineWalterFiona. 2016. “Member Checking: A Tool to Enhance Trustworthiness or Merely a Nod to Validation?”Qualitative Health Research26:1802–811. doi: 10.1177/1049732316654870.
9.
BoeriMiriam. 2018. Hurt: Chronicles of the Drug War Generation. 1st ed. Oakland, CA: University of California Press.
10.
BronfenbrennerUrie. 1999. “Ecological Systems Theory.”Annals of Child Development6:187–249.
ChristieNina C.2021. “The Role of Social Isolation in Opioid Addiction.”Social Cognitive and Affective Neuroscience16:645–56. doi:10.1093/scan/nsab029.
13.
Community Anti-Drug Coalition of America. 2010. Research Support for Comprehensive Community Interventions to Reduce Youth Alcohol, Tobacco and Drug Use and Abuse. Alexandria, VA: Community Anti-Drug Coalition of America.
14.
ConnerKyaien O.RosenDaniel. 2008. “‘You’re Nothing But a Junkie’: Multiple Experiences of Stigma in an Aging Methadone Maintenance Population.”Journal of Social Work Practice in the Addictions8:244–64. doi:10.1080/15332560802157065.
15.
CooperAmy E.CorriganPatrick W.WatsonAmy C.2003. “Mental Illness Stigma and Care Seeking.”Journal of Nervous and Mental Disease191:339–41. doi:10.1097/01.NMD.0000066157.47101.22.
16.
CorriganPatrick W.MarkowitzFred E.WatsonAmy C.2004. “Structural Levels of Mental Illness Stigma and Discrimination.”Schizophrenia Bulletin30(3):481–91. doi:10.1093/oxfordjournals.schbul.a007096.
17.
CorriganPatrick W.NieweglowskiKatherine. 2018. “Stigma and the Public Health Agenda for the Opioid Crisis in America.”International Journal of Drug Policy59:44–49. doi:10.1016/j.drugpo.2018.06.015.
18.
CourtwrightAndrew M.2009. “Justice, Stigma, and the New Epidemiology of Health Disparities.”Bioethics23:90–96. doi:10.1111/j.1467-8519.2008.00717.x.
19.
CushmanPaulJr1978. “Abstinence Following Detoxification and Methadone Maintenance Treatment.”The American Journal of Medicine65(1):46–52. doi:10.1016/0002-9343(78)90691-5.
20.
DarkeShaneHallWayne. 2003. “Heroin Overdose: Research and Evidence-based Intervention.”Journal of Urban Health80:189–200. doi:10.1093/jurban/jtg022.
21.
da SilveiraP. S.CaselaA. L. M.MonteiroÉ. P.FerrieraG. C. Lde FreitasJ. V. TMachadoN. M.NotoA. R.RonzaniT. M.2018. “Psychosocial Understanding of Self-stigma Among People Who Seek Treatment for Drug Addiction.”Stigma and Health3:42–52. doi:10.1037/sah0000069.
22.
DunlapBethCifuAdam S.2016. “Clinical Management of Opioid Use Disorder”. Journal of the American Medical Association316(3):338–339. doi:10.1001/jama.2016.9795.
23.
EvansDouglas N.Blount-HillKwan-LamarCubellisMichelle A.2019. “Examining Housing Discrimination Across Race, Gender and Felony History.”Housing Studies34(5):761–78. doi:10.1080/02673037.2018.1478069.
24.
FiellinDavid A.MooreBrent A.SullivanLynn E.BeckerWilliam C.PantalonMichael V.ChawarskiMarek C.BarryDeclan T.O’ConnorPatrick G.SchottenfieldRichard S.2008. “Long-term Treatment with Buprenoprhine/Naloxone in Primary Care: Results at 2-5 Years.”The American Journal on Addictions17(2):116–20. doi:10.1080/10550490701860971.
25.
FiellinDavid A.SchottenfeldRichard S.CutterChristopher J.MooreBrent A.BarryDeclan T.O’ConnorPatrick G.2014. “Primary Care-based Buprenorphine Taper Vs Maintenance Therapy for Prescription Opioid Dependence: A Randomized Clinical Trial.”JAMA Internal Medicine174(12):1947–54. doi:10.1001/jamainternmed.2014.5302.
26.
GalanterMarc. 2018. “Combining Medically Assisted Treatment and Twelve-step Programming: A Perspective and Review.”The American Journal on Drug Alcohol Abuse44(2):151–59. doi:10.1080/00952990.2017.1306747.
27.
GinterWalter. 2012. “Methadone Anonymous and Mutual Support for Medication-assisted Recovery.”Journal of Groups in Addiction and Recovery7(2–4):189–201. doi:10.1080/1556035X.2012.705699.
28.
GinzburgHarold M.1985. “Naltrexone: Its Clinical Utility.”Advances in Alcohol and Substance Abuse5(1–2):83–101. doi:10.1300/J251v05n01_07.
29.
GoffmanErving. 1974. Frame Analysis: An Essay on the Organization of Experience. Cambridge, MA: Harvard University Press.
30.
GoffmanErving. 1986. Stigma: Notes on the Management of Spoiled Identity. New York: Simon and Schuster.
31.
GoldMark S.BaronDavidBowirratAbdallaBlumKenneth. 2020. “Neurological Correlates of Brain Reward Circuitry Linked to Opioid Use Disorder (OUD): Do Homo Sapiens Acquire or Have a Reward Deficiency Syndrome?”Journal of the Neurological Sciences418:117137. doi:10.1016/j.jns.2020.117137.
32.
GruberValerie A.DelucchiKevin L.KielsteinAnoushehBatkiSteven L.2008. “A Randomized Trial of Six-month Methadone Maintenance with Standard or Minimal Counseling Versus 21-day Methadone Detoxification.”Drug and Alcohol Dependence94:199. doi:10.1016/j.drugalcdep.2007.11.021.
33.
HardingGeoffrey. 1986. “Constructing Addiction as a Moral Failing.”Sociology of Health and Illness8(1):75–85. doi:10.1111/1467-9566.ep11346491.
34.
HeatherNick. 2017. “Q: Is Addiction a Brain Disease or a Moral Failing? A: Neither.”Neuroethics10:115–24. doi:10.1007/s12152-016-9289-0.
35.
HeijndersMiriamVan Der MeijSuzanne. 2006. “The Fight Against Stigma: An Overview of Stigma-reduction Strategies and Interventions.”Psychology, Health, and Medicine11(3):353–63. doi:10.1080/13548500600595327.
36.
HelmStandifordTrescotAndrea M.ColsonJamesSehgalNaliniSilvermanSanford. 2008. “Opioid Antagonists, Partial Agonists/Antagonists: The Role of Office-based Detoxification.”Pain Physician11(2):225–35. doi:10.36076/ppj.2008/11/225.
37.
HewellValerie M.VasquezAngel R.RivkinInna D.2017. “Systemic and Individual Factors in the Buprenorphine Treatment-seeking Process: A Qualitative Study.”Substance Abuse Treatment, Prevention, and Policy12:3. doi:10.1186/s13011-016-0085-y.
38.
LeeJoshua D.FriedmannPeter D.KinlockTimothy W.NunesEdward V.BoneyTamara Y.HoskinsonRandall A.Jr.WilsonDonnaMcDonaldRyanRotrosenJohnGourevitchMarc N.MichaelGordonFishmanMarcChenDonna T.BonnieRichard J.CornishJames W.MurphySean M.O’BrienCharles P.2016. “Extended-release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.”New England Journal of Medicine374(13):1232–42. doi:10.1056/NEJMoa1505409.
39.
LincolnYvonna S.GubaEgon G.1985. Naturalistic Inquiry. Newbury Park, CA: Sage Publications.
40.
LingWalterAmassLeslieShoptawSteveAnnonJeffrey J.HillhouseMaureenBabcockDeanBrighamGregHarrerJudyReidMalcolmMuirJoanBuchanBettyOrrDebbieWoodyGeorgeKrejciJonathanZiedonisDouglas, and the Buprenorphine Study Protocol Group. 2005. “A Multi-center Randomized Trial of Buprenorphine-naloxone Versus Clonidine for Opioid Detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network.”Addiction100(8):1090–1100. doi:10.1111/j.1360-0443.2005.01154.x.
41.
LingWalterHillhouseMaureenDomierCatherineDoraimaniGeethaHunterJeremyThomasChristieJenkinsJessicaHassonAlbertAnnonJeffreySaxonAndrewSelzerJeffreyBovermanJoshuaBilangiRichard. 2009. “Buprenorphine Tapering Schedule and Illicit Opioid Use.”Addiction104(2):256–65. doi:10.1111/j.1360-0443.2008.02455.x.
42.
LuomaJason B.TwohigMichael P.WaltzThomasHayesSteven C.RogetNancyPadillaMichelleFisherGary. 2007. “An Investigation of Stigma in Individuals Receiving Treatment for Substance Abuse.”Addictive Behaviors32(7):1331–46. doi:10.1016/j.addbeh.2006.09.008.
43.
LuomaJason B.KulescaMagdalenaStevenC. Hayes, Barbara Kohlenberg, and Mary Larimer. 2014. “Stigma predicts residential treatment length for substance use disorder.” The American Journal of Drug and Alcohol Abuse40(3):206–212. doi:10.3109/00952990.2014.901337.
44.
MaJunBaoYan-PingWangRu-JiaSuMeng-FanLiuMo-XuanLiJin-QiaoDegenhardtLouisaFarrellMichaelBlowFrederic C.IlgenMarkShiJieLuLin. 2019. “Effects of Medication-assisted Treatment on Mortality Among Opioids Users: A Systematic Review and Meta-analysis.”Molecular Psychiatry24:1868–83. doi:10.1038/s41380-018-0094-5.
45.
MaddenErin Fanning. 2019. “Intervention Stigma: How Medication-assisted Treatment Marginalizes Patients and Providers.”Social Science and Medicine232:324–31. doi:10.1016/j.socscimed.2019.05.027.
46.
MaguraStephenRosenblumAndrew. 2001. “Leaving Methadone Treatment: Lessons Learned, Lessons Forgotten, Lessons Ignored.”The Mount Sinai Journal of Medicine68(1):62–74.
47.
MarshallKerryMainaGeoffreySherstobitoffJordan. 2021. “Plausibility of Patient-centred Care in High-intensity Methadone Treatment: Reflections of Providers and Patients.”Addiction Science and Clinical Practice16:42. doi:10.1186/s13722-021-00251-9.
48.
McCuskerJ.BigelowC.LuippoldR.ZornM.LewisB. F.1995. “Outcomes of a 21-day Drug Detoxification Program: Retention, Transfer to Further Treatment, and HIV Risk Reduction.”American Journal of Drug and Alcohol Abuse21(1):1–16. doi:10.3109/00952999509095225.
49.
MeadowsDonella. 2008. Thinking in Systems: A Primer, Edited by Diana Wright, Sustainability Institute. White River Junction, VT: Chelsea Green Publishing.
50.
MertonRobert K.KendallPatricia L.1946. “The Focused Interview.”American Journal of Sociology51(6). doi:10.1086/219886.
51.
MojtabaiRaminMauroChristineWallMelanie M.BarryColleen L.OlfsonMark. 2019. “Medication Treatment for Opioid Use Disorders in Substance Use Treatment Facilities.”Health Affairs (Millwood)38(1):14–23. doi:10.1377/hlthaff.2018.05162.
52.
MustoDavid F.1999. The American Disease: Origins of Narcotic Control. New York: Oxford University Press.
NosykBohdanSunHuiyingEvansElizabethMarshDavid C.AnglinM. DouglasHserYih-IngAnisAslam H.2012. “Defining Dosing Pattern Characteristics of Successful Tapers Following Methadone Maintenance Treatment: Results from a Population-based Retrospective Cohort Study.”Addiction107(9):1621–29. doi:10.1111/j.1360-0443.2012.03870.x.
56.
OlsenYngvildSharfsteinJoshua M.2014. “Confronting the Stigma of Opioid Use Disorder and Its Treatment.”JAMA311(14):1393–94. doi:10.1001/jama.2014.2147.
57.
PerryBrea L.PescosolidoBernice A.KrendlAnne C.2020. “The Unique Nature of Public Stigma Toward Non-medical Prescription Opioid Use and Dependence: A National Study.”Addiction115:2317–26. doi:10.1111/add.15069.
58.
PescosolidoB. A.MartinJ. K.2015. “The Stigma Complex.”Annual Review of Sociology41:87–116. doi:10.1146/annurev-soc-071312-145702.
RogersJennifer L.GilbrideDennis D.DewBrian J.2018. “Utilizing an Ecological Framework to Enhance Counselors’ Understanding of the U.S. Opioid Epidemic.”The Professional Counselor8(3):226–39. doi:10.15241/jlr.8.3.226.
61.
SaldañaJohnny. 2016. The Coding Manual for Qualitative Researchers. Los Angeles, CA: Sage Publications.
62.
ScottKelliMurphyCara M.YapKimberlyMoulSamanthaHurleyLindaBeckerSara J.2021. “Health Professional Stigma as a Barrier to Contingency Management Implementation in Opioid Treatment Programs.”Translational Issues in Psychological Science7(2):166–76. doi:10.1037/tps0000245.
63.
SeesKaren L.DelucchiKevin L.MassonCarmenRosenAmyClarkWestleyRobillardHelenBanysPeterHallSharon. 2000. “Methadone Maintenance vs. 180-Day Psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial.” Journal of the American Medical Association283(10): 1303–1310.
64.
SeifertJ.MetznerC.PaetzoldW.BorutzkyM.OhlmeierM.PassieT.HauserU.BeckerH.WieseB.EmrichH. M.SchneiderU.2006. “Mood and Affect During Detoxification of Opiate Addicts: A Comparison of Buprenorphine Versus Methadone.”Addiction Biology10(2):157–64. doi:10.1080/13556210500123191.
65.
SmithLaramie R.EarnshawValerie A.CopenhaverMichael M.CunninghamChinzao O.2016. “Substance Use Stigma: Reliability and Validity of a Theory-based Scale for Substance-using Populations.”Drug and Alcohol Dependence162:34–43. doi:10.1016/j.drugalcdep.2016.02.019.
66.
SmythB. P.BarryJ.KeenanE.DucrayK.2010. “Lapse and Relapse Following Inpatient Treatment of Opiate Dependence.”Irish Medical Journal103(6):176–79.
67.
SnedkerKaren A.HertingJerald R.WaltonEmily. 2009. “Contextual Effects and Adolescent Substance Use: Exploring the Role of Neighborhoods.”Social Science Quarterly90(5):1272–97. doi:10.1111/j.1540-6237.2009.00677.x.
68.
SnowDavid A. E.RochfordBurkeJr.WordenSteven K.BenfordRobert D.1986. “Frame Alignment Processes, Micromobilization, and Movement Participation.”American Sociological Review51:464–81. doi:10.2307/2095581.
69.
SoeffingJanet M.MartinL. DavidFingerhoodMichael I.JasinksiDonald R.RastegarDarius A.2009. “Buprenorphine Maintenance Treatment in Primary Care Setting: Outcomes at 1 Year.”Journal of Substance Abuse Treatment37(4):426–30. doi:10.1016/j.jsat.2009.05.003.
70.
StewartDavid W.ShamdasaniPrem N.RookDennis W.2007. Focus Groups: Theory and Practice. 2nd ed.New York: Sage Publications.
71.
StewartRebecca E.WolkCourtney BenjaminNeimarkGeoffreyVyasRidhiYoungJodynTjoaChrisKampmanKyleJonesDavid T.MandellDavid S.2021. “It’s Not Just the Money: The Role of Treatment Ideology in Publicly Funded Substance Use Disorder Treatment.”Journal of Substance Abuse Treatment120:108176. doi:10.1016/j.jsat.2020.108176.
72.
StimmelBarryGoldbergJudithRotkopfEdithCohenMurry. 1977. “Ability to Remain Abstinent After Methadone Detoxification: A Six-year Study.”JAMA237(12):1189–1292. doi:10.1001/jama.1977.03270390032021.
73.
StrangJohnMcCambridgeJimBestDavidBeswickTracyBearnJennyReesSianGossopMichael. 2003. “Loss of Tolerance and Overdose Mortality After Inpatient Opiate Detoxification: Follow Up Study.”British Medical Journal326(7396):959–60. doi:10.1136/bmj.326.7396.959.
74.
StraussAnselmCorbinJuliet. 1994. “Grounded Theory Methodology: An Overview.” Pp. 273–284 in Handbook of Qualitative Research. 1st ed., edited by NormanDenzinLincolnYvonna S.Thousand Oaks, CA: Sage Publications.
ThombsRyan P.ThombsDennis L.JorgensonAndrew K.BraswellTaylor Harris. 2020. “What Is Driving the Drug Opioid Overdose Epidemic in the United States?”Journal of Health and Social Behavior61(3):274. doi:10.1177/0022146520945607.
79.
TsaiAlexander C.KiangMathew V.BarnettMichael L.BeletskyLeoKeyesKatherine M.McGintyEmma E.SmithLaramie R.StrathdeeSteffanie A.WakehmanSarah E.VenkataramaniAtheendar S.2019. “Stigma as a Fundamental Hindrance to the United States Opioid Overdose Crisis Response.”PLoS Medicine16(11):e1002969. doi:10.1371/journal.pmed.1002969.
80.
van BoekolLeoniekeBrouwersEvelien P. M.van WeeghelJaapGarretsenHenk F. L.2013. “Stigma Among Health Professionals Towards Patients with Substance Use Disorders and Its Consequences for Healthcare Delivery: Systematic Review.”Drug and Alcohol Dependence131:23–35. doi:10.1016/j.drugalcdep.2013.02.018.
81.
WeissRoger D.PotterJennifer SharpeFiellinDavid A.ByrneMarilynConneryHilary S.DickinsonWilliamGardinJohnGriffinMargaret L.GourevitchMarc N.HallerDeborah L.HassonAlbert L.HuangZhenJacobsPetraKosinskiAnderzej S.LindbladRobertMcCance-KatzElinore F.ProvostScott E.SelzerJeffreySomozaEugene C.SonneSusan C.LingWalter. 2011. “Adjunctive Counseling During Brief and Extended Buprenorphine-naloxone Treatment for Prescription Opioid Dependence: A 2-phase Randomized Controlled Trial.”Archives of General Psychiatry68(12):1238–46. doi:10.1001/archgenpsychiatry.2011.121.
82.
WinesJames D.Jr.SaitzRichardHortonNicholas J.Lloyd-TravagliniChristineSametJeffrey H.2007. “Overdose After Detoxification: A Prospective Study.”Drug and Alcohol Dependence 89(2–3):161–69. doi:10.1016/j.drugalcdep.2006.12.019.
83.
WitteTricia H.JaiswalJessicaMumbaMercy N.MugoyaGeorge C. T.2021. “Stigma Surrounding the Use of Medically Assisted Treatment for Opioid Use Disorder.”Substance Use & Misuse56(10):1467–75. doi:10.1080/10826084.2021.1936051.
84.
WuLi-TzyZhuHeSwartzMarvin S.2016. “Treatment Utilization Among Persons with Opioid Use Disorder in the United States.”Drug and Alcohol Dependence169:117–27. doi:10.1016/j.drugalcdep.2016.10.015.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
